Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > The chat

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Feb 11, 2021 11:04am

54 Views

Post# 32537656

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The chat

So we are in agreement that investors have to understand the potential of R&D programs scientific and financials.

jfm1330 wrote: No disrespect intended, but not every business are raising capital on the back of science in animals being applicable to humans with possibility of total failure. Buffet was never in highly speculative companies like that. His motto was to only invest in what he was able to understand.

SPCEO1 wrote: No disrespect intended but you are off the mark here. Wise capital acquisition and allocation is important in every business.

jfm1330 wrote: Buffett never managed a biotech in need of cash to develop high risk clinical projects. Sorry, but the comparison is not relevant.

SPCEO1 wrote: Buffett would never have done that deal,